Researchers wrestle a matter of semantics

Tools to find "intersections in science" that can speed drug discovery are the objective of a semantic technology effort now underway by Alitora Systems and The J. David Gladstone Institutes. "Throw-away data in one area of research, may be critical in another," says Bruce Conklin, a senior cardiovascular disease investigator at Gladstone.

Semantic technology lets researchers search document and database information in a single network, according to an announcement. The searches are said to find information based on relevant meaning rather than keywords, yielding information from previously published work--even in other disciplines. 

"Meaning-based search technologies reveal closely related information not easily found through regular search strategies," says Alitora CEO Peter Berger, in the announcement.

Separately, semantic technology practitioners are collaborating on a project called SEALS, for semantic evaluation at large scale. The goal is to develop an infrastructure for remote evaluation of the technologies to help researchers compare them.

- read the announcement
- here's information on SEALS

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.